Sun Pharma announced its 34th AGM on July 31, 2026, and proposed a final dividend of ₹5 per share for FY26. Shareholders must meet the July 7, 2026, record date for eligibility.

Sun Pharma Schedules AGM, Proposes Final Dividend

Sun Pharmaceutical Industries Limited has announced its 34th Annual General Meeting (AGM) will be held on July 31, 2026, via video conferencing. The company also proposed a final dividend of ₹5 per equity share for the financial year 2025-26.

Reader Takeaway: Annual governance meeting and dividend payout confirm timeline; investors note record date.

What just happened

Sun Pharma has set July 31, 2026, as the date for its 34th Annual General Meeting. Shareholders will vote on various proposals, including the declaration of a final dividend of ₹5 per equity share for the financial year 2025-26. The company has fixed July 7, 2026, as the record date for determining dividend eligibility.

Why this matters

This announcement provides clarity on key corporate actions. The proposed dividend offers a direct return to shareholders, subject to their approval at the AGM. The AGM date also signals the formal conclusion of the company's financial year reporting and governance cycle.

The backstory

Sun Pharmaceutical Industries is a global pharmaceutical company with a significant presence in India and international markets. It is known for its generic and specialty medicines. Such announcements regarding AGMs and dividends are standard corporate governance practices for listed entities.

What changes now

Shareholders need to ensure their contact information is up-to-date with their depository participants or registrar to receive AGM notices and annual reports. Those seeking specific TDS rates on their dividend must submit necessary documentation by July 7, 2026.

Risks to watch

The dividend payout is contingent on shareholder approval at the AGM. While typically a formality, any significant dissent could theoretically impact the payout, although this is uncommon for final dividends.

Peer comparison

Most large-cap pharmaceutical companies follow a similar pattern of holding AGMs and declaring dividends. The ₹5 per share dividend amount will be assessed against the company's payout history and peer company practices when further financial data for FY26 is available.

Context metrics (time-bound)

• AGM Date: 31 July 2026
• Record Date: 07 July 2026
• Tentative Payment Date: On or before 07 August 2026
• Dividend per Share: ₹5

What to track next

Investors should monitor the outcome of the AGM for dividend approval and track the company's future dividend policy announcements.